Table 1 Patients characteristics.
From: Insulin resistance is linked to a specific profile of immune activation in human subjects
Characteristic | Variable | All profiles | Profile 1 (N = 43) | Profile 2 (N = 22) | Profile 3 (N = 39) | Profile 4 (N = 41) | Profile 5 (N = 5) |
|---|---|---|---|---|---|---|---|
Age | Mean (SD) | 61.7 (4.3) | 61.4 (4.6) | 61.8 (4.8) | 62.8 (4.3) | 61.2 (3.8) | 61.0 (2.1) |
Sex | |||||||
Female | % | 48 | 67 | 23 | 59 | 39 | 20 |
Male | % | 52 | 33 | 77 | 41 | 61 | 80 |
Ethnicity | |||||||
African | % | 8 | 10 | 14 | 10 | 2 | 0 |
Caucasian | % | 92 | 90 | 86 | 90 | 98 | 100 |
Body Mass Index | Mean (SD) | 26.6 (4.6) | 25.6 (4.9) | 27.3 (5.0) | 26.8 (4.0) | 27.4 (4.9) | 25.8 (4.8) |
Waist circumference (cm) | Mean (SD) | 88.8 (13.3) | 85.5 (14.2) | 93.4 (14.0) | 87.6 (10.5) | 90.6 (13.3) | 90.8 (16.3) |
Female | Mean (SD) | 81.5 (10.8) | 78.2 (11.2) | 80.6 (9.0) | 83.6 (10.9) | 83.4 (10.8) | 95.0 |
Male | Mean (SD) | 95.5 (11.5) | 94.5 (11.8) | 95.4 (10.7) | 96.9 (13.1) | 94.9 (12.3) | 91.7 (9.8) |
Hip circumference (cm) | Mean (SD) | 100.5 (8.6) | 99.5 (8.6) | 99.6 (8.7) | 102.2 (8.3) | 100.6 (8.6) | 97.2 (10.2) |
Systolic blood pressure (mmHg) | Mean (SD) | 138 (17) | 137 (20) | 141 (12) | 137 (17) | 138 (19) | 137 (20) |
Diastolic blood pressure (mmHg) | Mean (SD) | 83 (10) | 81 (11) | 84 (8) | 83 (10) | 82 (10) | 84 (9) |
Glycemia (mM) | Mean (SD) | 5.58 (1.17) | 5.54 (1.51) | 6.16 (1.70) | 5.36 (0.69) | 5.56 (0.82) | 5.40 (0.60) |
Cholesterol (mM) | Mean (SD) | 2.24 (0.45) | 2.22 (0.36) | 2.26 (0.55) | 2.20 (0.53) | 2.25 (0.42) | 2.31 (0.42) |
HDL (mM) | Mean (SD) | 0.59 (0.16) | 0.65 (0.20) | 0.55 (0.14) | 0.60 (0.13) | 0.55 (0.13) | 0.58 (0.13) |
LDL (mM) | Mean (SD) | 1.42 (0.38) | 1.36 (0.30) | 1.40 (0.45) | 1.40 (0.43) | 1.49 (0.39) | 1.49 (0.38) |
Triglyceridemia (mM) | Mean (SD) | 1.19 (0.68) | 1.12 (0.64) | 1.54 (1.03) | 1.09 (0.54) | 1.15 (0.59) | 1.26 (0.57) |
Insulinemia (μU/mL) | Mean (SD) | 10.2 (6.3) | 9.7 (5.6) | 13.3 (9.2) | 9.3 (5.4) | 10.1 (5.7) | 9.5 (7.3) |
Antidiabetic therapy | Number (%) | 9 (6%) | 4 (9%) | 3 (14%) | 1 (3%) | 1 (2%) | 0 (0%) |
Antihyperlipidemic therapy | Number (%) | 31 (21%) | 6 (14%) | 8 (36%) | 10 (26%) | 6 (15%) | 0 (0%) |
High blood pressure therapy | Number (%) | 36 (24%) | 8 (19%) | 7 (32%) | 10 (26%) | 8 (19%) | 0 (0%) |
